Compugen (CGEN)
$1.59 -$0.02 (-0.97%) 12:03 PM 12/13/24
NASDAQ | $USD | BiotechnologyStock Data
-
Market Cap
$147.74M -
Day's Range
$1.55 - $1.64 -
Volume
527,674 -
52 Week Low / High
$0.71 - $3.03 -
PE Ratio
55.00x -
PEG Ratio
- -
Dividend Frequency
-
CGEN's Dividend
Hypothetical 10k Investment Jan 1, 2020
- Capital Growth
- Dividend Return to Date
- Dividend Payout year Est.
- Expenses
- Total Return
- Total Return %
Analyists Ranking
- 3
- Strong Buy
- 0
- Buy
- 0
- Hold
- 0
- Sell
- 0
- Strong Sell
- $4.67
- Target Price
Company News
-
Compugen to Receive Milestone Payment Triggered by Dosing of First Patient in the Second Phase 3 Trial Evaluating Rilvegostomig — May 30th, 2024
Phase 3 trial evaluating rilvegostomig as monotherapy and in combination with AstraZeneca and Daiichi Sankyo's datopotamab deruxtecan in first-line nonsquamous non-small cell lung cancer Broadening the assessment of rilvegostomig reinforces Compugen's partnering strategy to expand opportu...
|
Portfolio
$5,000/year
Goal: $10,000/year
Comprised of 1 portfolios
$